SupplySide West is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Oct. 27-30, 2025
Expo Hall Oct. 29 & 30
Mandalay Bay, Las Vegas
Flagship sponsor:
Turning science into opportunity: ClostraBio’s SupplySide Global journey
Discover how CEO Ritu Shah leveraged SupplySide Global to connect with industry leaders, explore new commercial pathways, and accelerate the launch of CLB101™, a next-generation probiotic.
From biotech vision to real-world impact
ClostraBio is on a mission to tackle gut barrier dysfunction with science-driven solutions. Their lead product, CLB101™, is a next-generation, butyrate-producing probiotic designed to improve gut health and reduce inflammation.
When Ritu Shah first attended SupplySide Global in 2023, she came seeking more than just exposure — she wanted to connect with the right partners, gain insights into market channels, and find ways to bring CLB101™ to the people who need it most. The event delivered on all fronts, helping ClostraBio turn a complex scientific mission into actionable business opportunities.
“SupplySide Global opened doors we didn’t even know existed for our company.”
Strategic connections
Networking that drives growth
With careful planning and guidance from an industry advisor, Ritu and her team mapped out key brands and investors ahead of the event. They scheduled meetings, reached out to prospects in advance, and entered the show prepared.
During SupplySide Global, they connected with Nature’s Way, ADM, Kerry, and Nestle Health Sciences — relationships that led to funding opportunities, co-development discussions, and critical insights into the practitioner channel, a previously untapped route for reaching health care professionals.
Learning and industry insights
Knowledge that informs action
Beyond networking, SupplySide Global provided educational opportunities that shaped ClostraBio’s regulatory and commercial strategy. Sessions highlighted science-backed marketing, regulatory compliance, and successful product positioning, giving Ritu’s team the confidence to move CLB101™ closer to market readiness.
“The in-person connections at SupplySide Global gave us credibility and opened doors we couldn’t have reached virtually.”
Commercial growth
From conversations to market-ready strategies
Interactions with Nature’s Way and other partners revealed a practitioner-focused channel for CLB101™, providing a path for educating health care professionals and early adopters. These connections also guided ClostraBio’s marketing and clinical planning, helping accelerate the product’s launch and establish the company as a thought leader in next-generation gut health.
Lessons learned and future vision
Pioneering the next generation of probiotics
Key takeaways for Ritu and ClostraBio:
- Strategic planning amplifies trade show impact
- In-person networking accelerates commercial growth
- Science-driven insights shape product strategy
Looking ahead, ClostraBio is expanding its R&D pipeline and refining probiotic solutions for gut health. SupplySide Global will continue to be a critical platform for connecting with partners, sharing innovation, and staying at the forefront of the industry.
“SupplySide Global helped us translate a scientific vision into tangible business progress.”
Take the first step toward your own breakthrough
Join SupplySide Global and experience how connections, insights, and innovation come together to drive industry growth.
Copyright © 2025. All rights reserved. Informa Markets, a trading division of Informa PLC.